Sodium bicarbonate in critical illness: targeted or too broad? Author's reply
- PMID: 40828467
- DOI: 10.1007/s00134-025-08091-w
Sodium bicarbonate in critical illness: targeted or too broad? Author's reply
Conflict of interest statement
Declarations. Conflicts of interest: All authors have no conflict of interest to declare. Ethical approval: This is an author’s reply to a letter. Ethics approval is not applicable.
References
-
- Chen Q, Zheng Q (2025) Sodium bicarbonate in critical illness: targeted or too broad? Intensive Care Med. https://doi.org/10.1007/s00134-025-08085-8 - DOI - PubMed - PMC
-
- Blank SP, Blank RM, Laupland KB et al (2025) Sodium bicarbonate administration for metabolic acidosis in the intensive care unit: a target trial emulation. Intensive Care Med 51:1078–1086. https://doi.org/10.1007/s00134-025-07979-x - DOI - PubMed - PMC
-
- Igelström E, Craig P, Lewsey J et al (2022) Causal inference and effect estimation using observational data. J Epidemiol Community Health 76:960–966. https://doi.org/10.1136/jech-2022-219267 - DOI
-
- Jaber S, Paugam C, Futier E et al (2018) Sodium bicarbonate therapy for patients with severe metabolic acidaemia in the intensive care unit (BICAR-ICU): a multicentre, open-label, randomised controlled, phase 3 trial. Lancet Lond Engl 392:31–40. https://doi.org/10.1016/S0140-6736(18)31080-8 - DOI
-
- Jung B, Huguet H, Molinari N, Jaber S (2023) Sodium bicarbonate for the treatment of severe metabolic acidosis with moderate or severe acute kidney injury in the critically ill: protocol for a randomised clinical trial (BICARICU-2). BMJ Open 13:e073487. https://doi.org/10.1136/bmjopen-2023-073487 - DOI - PubMed - PMC
Publication types
LinkOut - more resources
Full Text Sources
